Recent work from several laboratories have demonstrated that delivery of AAV- or lentivirus-NF-α1/CPE or upregulation of NF-α1/CPE expression by agomirs can rescue AD pathology and ameliorate cognitive decline in three different AD mouse models [13, 44, 45]. This evidence concerns the gene CPE and Alzheimer disease.